Vascular Medicine News

Oral semaglutide demonstrated an approximately 14% reduction in major adverse CV events compared with standard care along in patients with diabetes, CVD and/or kidney disease, according to the top-line results of the phase 3 SOUL trial.

BOSTON — In a survey, cardiology physicians expressed hesitancy to prescribe currently available obesity medications, preferring exercise and dietary interventions, but with little personalized tailoring for patients, researchers reported.

There have been many recent regulatory updates in the areas of blood pressure management, dyslipidemia and diabetes management, speakers reported.

The ketogenic diet could reduce the risk for all-cause mortality by up to 24%, an analysis published in Scientific Reports showed.

The 19th annual Cardiometabolic Health Congress will be held at the Boston Park Plaza and will feature the latest science in the areas of cardio-renal, obesity, diabetes and dyslipidemia, atherosclerosis, thrombosis and more.

Fewer patients with bronchiectasis vs. COPD had at least one cardiovascular comorbidity/risk factor, according to results published in Respiratory Medicine.

Among younger women in the Middle East, those with overweight or obesity were more likely to have hypertension, diabetes and pregnancy-related issues than those without it, according to data from the ANCORS-YW study.

For pregnant women on bed rest, a foam roller intervention improved lower limb venous blood flow compared with controls, mitigating deep vein thrombosis risk and muscle atrophy, researchers reported.

Commonly used ways of positioning a patient’s arm during BP screenings may significantly overestimate BP and result in misdiagnosis of hypertension and overtreatment, an analysis suggested.

The Society for Cardiovascular Angiography and Interventions has released a consensus statement on how catheterization laboratories should manage the technical aspects of PCI for patients with STEMI.